Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma.
about
Yttrium-90 radioembolization of liver tumors: what do the images tell us?Radioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveGuidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: Report of Task Group 167.Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.Radioembolization of yttrium-90 microspheres for hepatic malignancy.Trans-arterial hepatic radioembolisation of yttrium-90 microspheres.Increased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose inhomogeneityEvaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration.PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment EfficacyFactors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignanciesPET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor ResponseClinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review.Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.Selective internal radiation therapy dosimetry.Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres.3D inpatient dose reconstruction from the PET-CT imaging of 90Y microspheres for metastatic cancer to the liver: feasibility study.Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology.Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies.Improved dose-volume histogram estimates for radiopharmaceutical therapy by optimizing quantitative SPECT reconstruction parameters.Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging.Determining the effects of microsphere and surrounding material composition on (90)Y dose kernels using egsnrc and mcnp5.Characterization of 90 Y-SPECT/CT self-calibration approaches on the quantification of voxel-level absorbed doses following 90 Y-microsphere selective internal radiation therapy.Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study.Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model.
P2860
Q26997064-D44E4496-EE7F-4878-83E1-E935C6B221DDQ26998661-8D1462BA-C6C3-4B6D-9E38-629C1A175751Q30151984-F1DD1180-7E12-4784-8107-0396929B8825Q33715683-7F76BFA0-5174-4A5D-9AA8-D184C71B5928Q34563515-8DA5FC51-6480-4405-A8FD-C4CF0AA75467Q34991390-04AF56C6-E6DD-46EE-A77C-D328F072B345Q35985132-DBD8D13F-5FCB-46FF-B6A1-62FC35E6DF63Q36157591-EE8BAD6B-C0E4-42D6-B0EB-EB4C9F4291FFQ36194191-42F6611C-EB7C-4BE0-B57A-2F12D9B7904EQ36656612-8E56FC8B-DD25-43F3-89B5-25F0A89A9399Q36874720-98E7977C-E64F-4289-82EA-29A2E2201F16Q37885238-BEF27AD3-BAFC-4871-9B7A-2F978097DFA0Q38206730-6885FEA1-E546-4691-B7AD-634EAF773163Q38283680-64B5B5E5-8426-4925-8623-0EFA3BBDB4CFQ38534001-4CBCDB3F-E551-4405-91E4-BE4ECFA60038Q39370311-A6975E7B-F47A-4A1E-A3E9-5F9E01D18208Q39637887-CAE6D22C-B16F-403E-BFEF-89F3C73571D4Q39706340-94FE3ABE-F936-4F2E-85A7-8C41E264B3C8Q42093398-D893771A-C54B-43F8-955B-6B86433CDD65Q44058512-8D8D91A2-433C-42C0-B901-BA6F31CB8CD3Q44936225-17F06594-7B18-46E7-9F19-5D90C4A6F0CDQ49672113-5931109C-4A4E-4B2D-A58B-843A235A6477Q52608240-9AEFE47A-15BD-4D48-9EA2-BAF12D441467Q55442958-A94AD147-41DA-4723-BAC4-41D06E5ECDBF
P2860
Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Radiation absorbed dose distri ...... for hepatocellular carcinoma.
@en
Radiation absorbed dose distri ...... for hepatocellular carcinoma.
@nl
type
label
Radiation absorbed dose distri ...... for hepatocellular carcinoma.
@en
Radiation absorbed dose distri ...... for hepatocellular carcinoma.
@nl
prefLabel
Radiation absorbed dose distri ...... for hepatocellular carcinoma.
@en
Radiation absorbed dose distri ...... for hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Radiation absorbed dose distri ...... for hepatocellular carcinoma.
@en
P2093
Andrew S Kennedy
Cedric X Yu
Martin A Lodge
Mehrdad Sarfaraz
X Allen Li
P2860
P304
P356
10.1118/1.1781332
P407
P577
2004-09-01T00:00:00Z